GlassScriptPhysician profile
John S Kelley
NPI 1750380705
$7,232.17
in general payments reported to CMS, 2019-2025
27 companies · $20.57 in 2025
The $20.57 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,110 · 2020: $1,170 · 2021: $2,386 · 2022: $819 · 2023: $727 · 2025: $20.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $4,251.84 | 2019-2022 | |
| Corindus INC. | $426.60 | 2019 | |
| Abiomed | $412.90 | 2019-2023 | Impella |
| Boston Scientific Corporation | $366.30 | 2022-2023 | Rotablator Rotational Atherectomy System Console Kit, Bodyguardian |
| Teleflex LLC | $274.31 | 2022 | |
| Shockwave Medical, INC | $229.83 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $203.70 | 2019-2023 | Farxiga |
| Novartis Pharmaceuticals Corporation | $117.12 | 2019 | |
| Angiodynamics, INC. | $117.07 | 2019 | |
| Janssen Pharmaceuticals, INC | $107.81 | 2019-2023 | Xarelto |
| Cardiovascular Systems INC. | $102.10 | 2019-2023 | Diamondback Coronary |
| Philips North America LLC | $93.15 | 2020-2025 | Extended Holter |
| Scpharmaceuticals INC. | $64.25 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $59.29 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $56.87 | 2019-2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $52.83 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $47.70 | 2019-2020 | |
| Nuwellis, INC. | $47.62 | 2019 | |
| Amgen INC. | $45.89 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $25.85 | 2019 | |
| Celgene Corporation | $22.41 | 2023 | Camzyos |
| Bard Access Systems, INC. | $22.06 | 2021 | |
| Merck Sharp & Dohme LLC | $20.31 | 2023 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $19.04 | 2019 | |
| Smith+Nephew, INC. | $16.77 | 2023 | Grafix Pl |
| Irhythm Technologies, INC. | $14.55 | 2020 | |
| Kestra Medical Technology Services, INC. | $14.00 | 2023 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kelley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.